Two vaccine injections DTP-pertussis-Hib
ApprovedVaccine
Two vaccine injections DTP-pertussis-Hib is one of 11 biologic programs targeting Poliomyelitis. It is currently in Approved.
1
Indications
1
Total Trials
0
Active Trials
10
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
30 competitors in Poliomyelitis
#DrugCompanyPhaseTrials
1Comparator: Pbo
Merck & Co.Phase 3
Rotateq
Merck & Co.Phase 3
Hepatitis B Vaccine
SanofiPhase 2
Inactivated Rabies Virus Vaccine
SanofiPhase 2
Two vaccine injections DTP-pertussis-Hib
CCentral Hospital, Nancy, France
Approved
Sipv
Sinovac Biotech Co., LtdApproved
Concomitant Administration
SanofiPhase 3
Oral NVB Metronomic
SanofiPhase 2
Verazinc
FFakultas Kedokteran Universitas Indonesia
Preclinical
Poliorix.
GSKPhase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Poliomyelitis1 trial
Diphtheria, Tetanus, Poliomyelitis -Pertussis-Hib Immunisation in Preterm-born Neonates
Unknown status·—·Phase 4·NCT02179996·160 enrolled
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Vaccine[2]
- Highest Phase
- Approved[1]
- Company
- CCentral Hospital, Nancy, France